anumigilimab   Click here for help

GtoPdb Ligand ID: 11761

Synonyms: CSL-324 | CSL324
Compound class: Antibody
Comment: Anumigilimab (CSL-324) is a clinical stage monoclonal antibody that targets colony stimulating factor 3 receptor (CSF3R). It was developed by CSL Behring for potential efficacy in inflammatory/autoimmune diseases. The heavy and light chain peptide sequences for anumigilimab are claimed in patent WO2012171057A1 [1].
Click here for help
1. Nash AD, Andrews AE, Baca M, Edwarda KM, Hardt MP, Panousis C, Dunlop FM. (2012)
Antibodies against g-csfr and uses thereof.
Patent number: WO2012171057A1. Assignee: Csl Limited. Priority date: 13/06/2011. Publication date: 20/12/2012.